You are here

  • Home
  • Archive
  • Volume 59, Issue 6
  • Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Article metrics

Article menu

Download PDFPDF

Inflammatory bowel disease
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial
Free

 

Online download statistics by month:

Online download statistics by month: May 2010 to March 2024

AbstractFullPdf
May 2010403121330
Jun 2010410288445
Jul 2010179179260
Aug 2010217196200
Sep 201064142148
Oct 2010499387
Nov 20105891103
Dec 2010705176
Jan 2011479877
Feb 2011737276
Mar 2011627769
Apr 2011374670
May 2011425249
Jun 2011203447
Jul 2011224152
Aug 2011103339
Sep 2011214529
Oct 2011437243
Nov 2011304823
Dec 2011344735
Jan 2012414619
Feb 2012482621
Mar 2012472726
Apr 2012613929
May 2012423832
Jun 2012405624
Jul 2012684726
Aug 2012454023
Sep 2012724228
Oct 2012655534
Nov 2012553635
Dec 2012455019
Jan 2013433116
Feb 2013694434
Mar 2013434228
Apr 2013523630
May 2013373926
Jun 2013373217
Jul 201325238
Aug 2013323423
Sep 2013331626
Oct 2013511821
Nov 2013402026
Dec 2013292526
Jan 2014342010
Feb 2014232624
Mar 2014301720
Apr 2014373119
May 2014282519
Jun 2014141010
Jul 2014244331
Aug 2014252720
Sep 2014152017
Oct 2014281923
Nov 2014302335
Dec 2014181017
Jan 2015131312
Feb 2015251919
Mar 2015142222
Apr 2015262622
May 2015302122
Jun 2015301822
Jul 2015201918
Aug 2015141612
Sep 2015231717
Oct 20151935
Nov 2015222119
Dec 201591412
Jan 2016271926
Feb 2016302318
Mar 2016201724
Apr 2016294625
May 201691911
Jun 201621111
Jul 2016172724
Aug 201623179
Sep 2016241510
Oct 2016401913
Nov 201610811
Dec 2016171912
Jan 20171468
Feb 20178916
Mar 201742612
Apr 20173228
May 201714112
Jun 2017102617
Jul 2017171512
Aug 201731296
Sep 201723239
Oct 2017333115
Nov 2017252310
Dec 2017393124
Jan 2018343315
Feb 2018251919
Mar 2018291911
Apr 2018373516
May 201831258
Jun 2018433316
Jul 2018453713
Aug 201826249
Sep 201831158
Oct 2018403627
Nov 2018554722
Dec 2018443313
Jan 2019232313
Feb 2019302517
Mar 2019292620
Apr 2019251715
May 2019322919
Jun 2019231932
Jul 2019333023
Aug 2019191629
Sep 2019262517
Oct 2019383118
Nov 2019171318
Dec 2019372629
Jan 2020271920
Feb 2020563216
Mar 2020343224
Apr 202021217
May 202022227
Jun 202027278
Jul 202032269
Aug 2020272411
Sep 202049386
Oct 2020444410
Nov 2020584511
Dec 2020746520
Jan 2021464220
Feb 2021696312
Mar 2021826926
Apr 2021322817
May 2021646324
Jun 2021292916
Jul 2021303030
Aug 2021232310
Sep 2021393814
Oct 2021373030
Nov 2021414141
Dec 202134359
Jan 2022575333
Feb 2022373517
Mar 2022373913
Apr 2022504823
May 2022474531
Jun 2022484722
Jul 2022373314
Aug 2022505015
Sep 2022454317
Oct 2022595332
Nov 2022312522
Dec 202237275
Jan 202344427
Feb 2023858114
Mar 202336288
Apr 2023362610
May 202336308
Jun 202330293
Jul 2023424113
Aug 202334347
Sep 2023626317
Oct 2023454412
Nov 202339388
Dec 202358502
Jan 202442439
Feb 202442426
Mar 2024454062
Total699863414900